争光股份 reported revenue of ¥0.29B for the period ended 2026-06-30, -12.7% year on year. Net income was ¥0.04B, a 13.5% net margin on a 32.4% gross margin. The largest revenue line is 离子交换与吸附树脂产品 at 100% of the total. Free cash flow for the period was ¥-0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.29B | -12.7% |
| Gross profit | ¥0.09B | — |
| Operating income | ¥0.04B | — |
| Net income | ¥0.04B | -28.1% |
| Gross margin | 32.4% | Net margin 13.5% |
| Revenue Q/Q | +26.1% | — |
| Segment | Revenue | Share |
|---|---|---|
| 离子交换与吸附树脂产品 | ¥0.28B | 99.6% |
| 其他(补充) | ¥0.00B | 0.4% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.19B | 67.6% |
| R&D | ¥0.02B | 5.6% |
| SG&A | ¥0.03B | 10.4% |
| Tax & other | ¥0.00B | 1.3% |
| Item | Amount |
|---|---|
| Total assets | ¥2.21B |
| Total liabilities | ¥0.25B |
| Shareholders' equity | ¥1.96B |
| Equity / assets | 88.7% |
| Operating cash flow | ¥0.03B |
| Capital expenditure | ¥0.04B |
| Free cash flow | ¥-0.01B |
| Cash conversion (OCF / net income) | 121% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
华兰股份 ・ 广立微 ・ 百诚医药 ・ 天益医疗 ・ 金埔园林 ・ 雅创电子 ・ 风光股份 ・ 明月镜片 ・ 兆讯传媒 ・ 何氏眼科 ・ 鸿铭股份 ・ 骏成科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies